Cochrane Evidence Synthesis and Methods ►

Mucolytics for children with chronic suppurative lung disease

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the effects of mucolytics for reducing exacerbations and improving quality of life in children with CSLD (including PBB and bronchiectasis), and to assess the risk of harm due to adverse events.

This is a protocol.

Published:

25 July 2022

Authors:

McElrea E, Chang AB, Yerkovich S, O'Farrell HE, Marchant JM

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
McElrea E, Chang AB, Yerkovich S, O'Farrell HE, Marchant JM. Mucolytics for children with chronic suppurative lung disease (Protocol). Cochrane Database of Systematic Reviews 2022, Issue 7. Art. No.: CD015313. DOI: 10.1002/14651858.CD015313.